Marksans Pharma Soars After FDA Greenlights New York Facility: What’s Next?
Marksans Pharma’s stock rises 1.86% following FDA approval of its New York facility. Discover the implications for investors and the pharmaceutical industry.
Flash News
Be aware: FDA Warns of Botulism Risks in Canned Desserts and Illegal Supplement Claims
The FDA warns of serious botulism risks in canned desserts and illegal claims in dietary supplements. Learn about health risks and safety measures to protect yourself.
Unlocking Compliance: Key Insights from the 2024 Energy Industry Survey
Discover key insights from the 2024 Energy Industry Compliance Survey, equipping organizations with strategies to enhance compliance and thrive amidst evolving regulations.
Navigating the New Age of Regulatory Compliance: Tech Solutions You Need
Discover how technology enables businesses to enhance regulatory compliance amid federal deregulation and diverse state challenges. Leverage AI and analytics for effective solutions.
Why U.S. Companies Must Rethink Cross-Border Data Transfers Now
U.S. firms face new challenges in cross-border data transfers amid rising geopolitical tensions. Learn key compliance strategies and enhance data security now.
Are Electronic Shelf Labels Worth the Risk for Retailers?
Discover the benefits and challenges of electronic shelf labels (ESLs) for retailers, including pricing issues, regulations, and consumer trust. Learn how to navigate these risks effectively.